Search

Your search keyword '"Grimaldi, L. M. E."' showing total 32 results

Search Constraints

Start Over You searched for: Author "Grimaldi, L. M. E." Remove constraint Author: "Grimaldi, L. M. E." Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
32 results on '"Grimaldi, L. M. E."'

Search Results

1. Signs and symptoms of COVID-19 in patients with multiple sclerosis

2. Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register

3. Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register

4. Signs and symptoms of COVID-19 in patients with multiple sclerosis

5. Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis

6. Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis

7. Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register

8. Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

9. Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study

13. Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register

14. Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis

17. The Italian multiple sclerosis register

18. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

19. No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study

20. Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial

21. Glucocorticoid-related genetic susceptibility for Alzheimer's disease

22. Reply

23. Cholesterol 25-hydroxylase on chromosome 10q is a susceptibility gene for sporadic Alzheimer's disease

27. Lack of association between the interferon regulatory factor-1 (IRF1) locus at 5q31.1 and multiple sclerosis in Germany, Northern Italy, Sardinia and Sweden.

30. Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

31. Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience

Catalog

Books, media, physical & digital resources